Northwest Investment Counselors’s Sana Biotechnology SANA Stock Holding History

Northwest Investment Counselors’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$3.12K	Buy	+750	New	+$3.94K	﹤0.01%	536
2024 Q2	–	Sell	-750	Closed	-$7.5K	–	427
2024 Q1	$7.5K	Buy	+750	New	+$5.62K	﹤0.01%	404
2023 Q4	–	Sell	-750	Closed	-$2.9K	–	446
2023 Q3	$2.9K	Hold	750	–	–	﹤0.01%	495
2023 Q2	$4.47K	Hold	750	–	–	﹤0.01%	463
2023 Q1	$2.45K	Hold	750	–	–	﹤0.01%	500
2022 Q4	$2.96K	Buy	+750	New	+$3.67K	﹤0.01%	499

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

Northwest Investment Counselors's SANA Position: Q3 2024 in Review

Northwest Investment Counselors opened a new position in Sana Biotechnology (SANA) in Q3 2024: 750 shares worth $3.12K. The stake represents ﹤0.01% of the portfolio and ranks #536 among its holdings. This is a return to the name: Northwest Investment Counselors previously reported a position in SANA as recently as Q1 2024.

Northwest Investment Counselors first reported a position in SANA in Q4 2022 and has held it in 6 quarters since. The position peaked at $7.5K in Q1 2024. 155 funds tracked by Wall St. Rank hold SANA as of Q3 2024.

Northwest Investment Counselors held 750 shares of Sana Biotechnology worth $3.12K as of Q3 2024.
Sana Biotechnology was a new Northwest Investment Counselors position in Q3 2024.
Sana Biotechnology made up ﹤0.01% of Northwest Investment Counselors's portfolio in Q3 2024, its #536 holding.
Northwest Investment Counselors first reported a position in Sana Biotechnology in Q4 2022 and has held it in 6 quarters since.
Northwest Investment Counselors's Sana Biotechnology position peaked at $7.5K in Q1 2024.
155 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2024.

Based on Northwest Investment Counselors's 13F filing for Q3 2024, filed 21 Oct 2024.